Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol in Friedreich Ataxia
NCT01339884Phase 2Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Apr 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of resveratrol in Friedreich ataxia (FA), sponsored by Murdoch Children's Research Institute. Started Apr 2011; status: completed.
02
Drugs
resveratrol
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT01339884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339884.